The first wave of COVID-19 in hospital staff members of a tertiary care hospital in the greater Paris area: A surveillance and risk factors study.
COVID-19
Control measures
Healthcare workers
Personal protective equipment
SARS-CoV-2
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
05
01
2021
revised:
08
02
2021
accepted:
11
02
2021
pubmed:
20
2
2021
medline:
14
5
2021
entrez:
19
2
2021
Statut:
ppublish
Résumé
Understanding how hospital staff members (HSMs), including healthcare workers, acquired severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave can guide the control measures in the current second wave in Europe. From March 5 to May 10, 2020, the Raymond-Poincaré Hospital held a weekday consultation for HSMs for PCR testing. HSMs were requested to complete a questionnaire on their potential exposure to SARS-CoV-2. Of 200 HSMs screened, 70 tested positive for SARS-CoV-2. Ninety-nine HSMs completed the questionnaire of whom 28 tested positive for SARS-CoV-2. In the multivariable analysis, age of ≥44 years (aOR = 5.2, 95% CI [1.4-22.5]) and not systematically using a facemask when caring for a patient (aOR = 13.9, 95% CI [1.8-293.0]) were significantly associated with SARS-CoV-2 infection. Working in a COVID-19-dedicated ward (aOR = 0.7, 95% CI [0.2-3.2]) was not significantly associated with infection. Community-related exposure in and outside the hospital, hospital meetings without facemasks (aOR = 21.3, 95% CI [4.5-143.9]) and private gatherings (aOR = 10, 95% CI [1.3-91.0]) were significantly associated with infection. Our results support the effectiveness of barrier precautions and highlight in-hospital infections not related to patient care and infections related to exposure in the community. Protecting HSMs against COVID-19 is crucial in fighting the second wave of the epidemic.
Identifiants
pubmed: 33607301
pii: S1201-9712(21)00141-7
doi: 10.1016/j.ijid.2021.02.055
pmc: PMC7884916
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
172-179Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
mSphere. 2020 Oct 21;5(5):
pubmed: 33087517
N Engl J Med. 2020 Aug 6;383(6):e38
pubmed: 32502334
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
J Hosp Infect. 2020 Oct;106(2):357-363
pubmed: 32702465
Elife. 2020 May 11;9:
pubmed: 32392129
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290904
JAMA. 2020 Dec 1;324(21):2155-2156
pubmed: 33185657
JAMA. 2020 Aug 18;324(7):703-704
pubmed: 32663246
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32521222
J Hosp Infect. 2020 Jun;105(2):353
pubmed: 32243947
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824